Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lifeline Scientific's share price for the quarter that ended in Jun. 2016 was £0. Lifeline Scientific's Shares Outstanding (EOP) for the quarter that ended in Jun. 2016 was 19.45 Mil. Therefore, Lifeline Scientific's market cap for the quarter that ended in Jun. 2016 was £0.00 Mil.
Lifeline Scientific's annual market cap
declined
from Dec. 2013 (£31.60 Mil) to Dec. 2014 (£0.00 Mil) but then
stayed the same
from Dec. 2014 (£0.00 Mil) to Dec. 2015 (£0.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lifeline Scientific's Enterprise Value for Today is £26.67 Mil.
Lifeline Scientific Market Cap Historical Data
The historical data trend for Lifeline Scientific's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lifeline Scientific's Market Cap
For the Medical Devices subindustry, Lifeline Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifeline Scientific's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's Market Cap distribution charts can be found below:
* The bar in red indicates where Lifeline Scientific's Market Cap falls into.
Lifeline Scientific Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Lifeline Scientific's Market Cap for the fiscal year that ended in Dec. 2015 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifeline Scientific (LSE:LSI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Lifeline Scientific Market Cap Related Terms
Thank you for viewing the detailed overview of Lifeline Scientific's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Lifeline Scientific (LSE:LSI) Business Description
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:LSI has been successfully added to your 